MacroGenics Inc.

NASDAQ: MGNX · Real-Time Price · USD
1.57
-0.05 (-3.09%)
At close: Aug 15, 2025, 3:59 PM
1.56
-0.64%
After-hours: Aug 15, 2025, 07:40 PM EDT

MacroGenics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
152.43M 148.34M 141.33M 41.02M 43.36M 58.47M 118.92M 150.26M 163.13M 149.59M 92.04M 65.88M 70.25M 75.64M 113.77M 115.6M 100.87M
Cost of Revenue
15.58M 12.3M 8.87M 7.09M 5.44M 6.85M 6.58M 9.63M 10.86M 7.38M 6.54M 5.06M 2.68M 2.65M 1.7M 39K 17K
Gross Profit
136.84M 136.04M 132.46M 33.93M 37.92M 51.62M 112.35M 140.63M 152.27M 142.21M 85.5M 60.82M 67.56M 72.99M 112.06M 115.56M 100.85M
Operating Income
-99.45M -110.58M -107.09M -196.79M -183.57M -168.24M -106.91M -96.36M -93.21M -121.42M -191.64M -219.67M -218.14M -202.79M -146.73M -129.88M -136.91M
Interest Income
8.41M 9.42M 10.62M 11.55M 11.31M 9.69M 8.1M 5.19M 3.42M 2.54M 841K 699K 195K n/a n/a n/a n/a
Pretax Income
-54.87M -66.02M -97.62M -136.37M -23.24M -9.06M 49.82M 7.45M -91.32M -119.76M -190.58M -218.66M -217.29M -202.12M -146.18M -129.34M -136.29M
Net Income
-55.81M -66.97M -97.62M -136.37M -23.24M -9.3M 49.58M 7.35M -91.42M -119.42M -190.25M -218.46M -217.09M -202.12M -146.18M -129.34M -136.29M
Selling & General & Admin
67.06M 71.05M 55.8M 54.1M 53.37M 52.19M 53.3M 56.25M 56.22M 58.95M 60.86M 62.67M 64.23M 63.01M 59.99M 52.56M 47.55M
Research & Development
170.86M 177.19M 183.75M 173.34M 164.84M 164.68M 164.88M 182.94M 191.46M 207.03M 217.23M 218.86M 222.89M 214.58M 201.02M 195.86M 197.43M
Other Expenses
-1.62M -1.62M n/a 3.27M 3.27M 2.99M 1.07M -2.06M -1.56M -1.71M 218K 177K -327K 122K 205K 196K 621K
Operating Expenses
236.29M 246.62M 239.55M 230.72M 221.48M 219.86M 219.25M 236.99M 245.48M 263.62M 277.13M 280.49M 285.7M 275.79M 258.79M 245.44M 237.76M
Interest Expense
97K 1.14M 1.14M 1.14M 1.91M 1.43M 1.43M 1.43M 656K n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
251.88M 258.92M 248.42M 237.81M 226.93M 226.71M 225.83M 246.62M 256.34M 271.01M 283.68M 285.55M 288.38M 278.44M 260.49M 245.48M 237.78M
Income Tax Expense
n/a n/a n/a n/a n/a 239K 239K 97K 97K -337K -337K -195K -195K n/a n/a n/a 270K
Shares Outstanding (Basic)
62.97M 62.62M 62.74M 62.66M 62.29M 62.07M 61.98M 61.88M 61.81M 61.43M 61.46M 61.38M 61.32M 61.17M 61.17M 60.07M 56.97M
Shares Outstanding (Diluted)
62.97M 62.62M 62.87M 62.66M 62.29M 62.07M 62.24M 62.26M 61.81M 61.43M 61.46M 61.38M 61.32M 61.17M 61.17M 60.07M 57.2M
EPS (Basic)
-0.89 -1.08 -1.57 -2.19 -0.37 -0.15 0.80 0.12 -1.48 -1.94 -3.1 -3.56 -3.55 -3.37 -2.46 -2.26 -2.54
EPS (Diluted)
-0.89 -1.08 -1.57 -2.19 -0.38 -0.16 0.79 0.11 -1.48 -1.94 -3.1 -3.56 -3.55 -3.37 -2.46 -2.26 -2.54
EBITDA
-47.33M -57.37M -89.09M -127.73M -12.83M 2.02M 61.4M 19.93M -79.55M -108.71M -179M -207.12M -205.84M -190.86M -135.07M -118.06M -125.19M
EBIT
-54.8M -64.91M -96.48M -135.23M -21.33M -7.63M 50.43M 8.06M -91.49M -120.58M -190.8M -218.97M -217.94M -202.79M -146.73M -129.88M -136.91M
Depreciation & Amortization
7.47M 7.54M 7.39M 7.5M 8.5M 9.64M 10.98M 11.87M 11.94M 11.87M 11.59M 11.54M 11.44M 11.26M 11.2M 11.36M 11.61M